Literature DB >> 16490562

Positron-emission tomography as a prognostic tool for early-stage lung cancer.

Alicia N Kieninger1, Robert Welsh, Phillip J Bendick, Gerald Zelenock, Gary W Chmielewski.   

Abstract

BACKGROUND: Positron-emission tomography (PET) shows tissue metabolic activity in the form of the standard uptake value (SUV). This study examines the prognostic value of the SUV for early-stage lung cancer.
METHODS: A retrospective review of 187 patients undergoing PET for potential lung cancer. Data collected included patient demographics, tumor pathology, and survival information. Data were correlated with PET results to determine if a prognostic relationship exists.
RESULTS: The sensitivity and specificity of PET for detecting malignant lesions were 98% and 24%. Malignant lesions had a higher SUV than benign lesions (5.9 +/- 6.2 versus 2.2 +/- 1.8, P < .0001). The average SUV of well-differentiated tumors was 2.6 +/- 3.1 versus 5.9 +/- 5.5 for other tumors (P = .010). There was a strong correlation between tumor stage and SUV (analysis of variance, P < .0001). There was no difference in tumor SUV for survivors versus nonsurvivors.
CONCLUSIONS: The SUV correlates with prognostic indicators, such as tumor stage and grade. The SUV alone was not an independent predictor of survival.

Entities:  

Mesh:

Year:  2006        PMID: 16490562     DOI: 10.1016/j.amjsurg.2005.10.052

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Fluorodeoxyglucose positron emission tomography integrated with computed tomography to determine resectability of primary lung cancer.

Authors:  Haruhiko Nakamura; Masahiko Taguchi; Hajime Kitamura; Junichi Nishikawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-08-13

2.  Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer.

Authors:  An-Na Tong; Shao-Rong Han; Peng Yan; Hai Gong; Hui Zhao; Hui Yao; Yan-Ming Wang
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

3.  Determination of prognostic factors of surgically treated pathological Stage IIIA non-small cell lung cancer.

Authors:  Muhammet Sayan; Elgun Valiyev; Merve Satır Türk; Aynur Baş; Ali Çelik; İsmail Cüneyt Kurul; Olgun Kadir Arıbaş; Abdullah İrfan Taştepe
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-07-28       Impact factor: 0.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.